NCT06608251View on ClinicalTrials.gov

Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Myelinopathy
Interventions
DIAGNOSTIC_TEST

white matter lesion

According to the results of magnetic resonance, they were divided into white matter degeneration group and non-white matter degeneration group

Trial Locations (1)

Unknown

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT06608251 - Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury | Biotech Hunter | Biotech Hunter